Benjamin Herzberg, MD

Benjamin Herzberg, MD Specialties: Medical Oncology

Benjamin Herzberg, MD
Specialties: Medical Oncology
phone icon
checkmark iconAccepting new patients


CUIMC/Herbert Irving Pavilion
161 Fort Washington Avenue
Floor 3
New York, NY 10032

insurance iconinsurance icon
Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • Affinity Health Plan
  • AgeWell
  • Amida Care
  • Emblem/GHI
  • Emblem/Hip
  • Empire Blue Cross Blue Shield Healthplus
  • Empire Blue Cross/Blue Shield
  • Fidelis Care
  • Healthfirst
  • Local 1199
  • Magnacare (National)
  • Medicare
  • Multiplan
  • MVP Health Care
  • Oxford Health Plans
  • Quality Health Management
  • RiverSpring
  • UnitedHealthcare
  • WellCare

about iconabout icon
About Benjamin Herzberg, MD

I am a board-certified medical oncologist specializing in the treatment of thoracic malignancies. I received my undergraduate degree from Princeton University, an MD from the combined Harvard Medical School and MIT Program in Health Sciences and Technology (HST), and an MSc in the History of Science and Medicine from Imperial College, London. I completed my internship and residency training in internal medicine at Massachusetts General Hospital, where I was a Stanbury Physician-Scientist trainee, and my fellowship in medical oncology at Memorial Sloan-Kettering Cancer Center, where I was Chief Fellow.

I see patients with all types of thoracic malignancies, including non-small cell lung cancer, small cell lung cancer, mesothelioma and thymoma. As someone whose own life was touched by cancer diagnoses, I work with a team of specialists to bring individual, compassionate care to each of my patients.

My research interests are in lung cancer and cancers with special difficulties repairing damage to their DNA. I develop clinical trials using novel agents targeting DNA repair, bringing these drugs directly to my patients in the clinic. My laboratory work aims to define new vulnerabilities in cancer cells which can be leveraged for more effective, less toxic therapy. This work has been recognized by several awards from the NIH and other organizations.

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center


  • Lung Cancer

  • Thoracic Cancer

  • Thoracic Oncology

  • Thymoma


  • Fellowship: Memorial Sloan-Kettering Cancer Center
  • Medical School: Harvard Medical School
  • Residency: Massachusetts General Hospital

Board Certifications

  • Medical Oncology